Tizanidine: Difference between revisions
>Goornie added citations |
>Tracer Added Category:Arylaminoimidazoline, romeved Category:Proofread and Category:Approval |
||
(10 intermediate revisions by 4 users not shown) | |||
Line 3: | Line 3: | ||
{{SubstanceBox/Tizanidine}} | {{SubstanceBox/Tizanidine}} | ||
'''Tizanidine''' (known by the trade names '''Zanaflex''' and '''Trinex''' among others) is a [[depressant]] substance of the | '''Tizanidine''' (known by the trade names '''Zanaflex''' and '''Trinex''' among others) is a [[depressant]] substance of the [[chemical class::arylaminoimidazoline]] class closely related to [[clonidine]]. Tizanidine is primarily used primarily as an antispasmodic drug. Tizanidine's effectivness is similar to that of [[baclofen]] or [[diazepam]] <ref> Wagstaff AJ, Bryson HM. Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders. Drugs. 1997 Mar;53(3):435-52. doi: 10.2165/00003495-199753030-00007. PMID: 9074844. </ref>. | ||
Tizanidine is a central α<sub>2</sub> adrenergic agonist. The relationship between the α<sub>2</sub> receptor agonism and the spasmolytic function of tizanidine is not fully understood <ref> Katzung, Bertram G. (30 November 2017). Basic & clinical pharmacology. Katzung, Bertram G. (Fourteenth ed.). New York. p. 487. ISBN 9781259641152. OCLC 1015240036 </ref> . | Tizanidine is a central α<sub>2</sub> adrenergic agonist. The relationship between the α<sub>2</sub> receptor agonism and the spasmolytic function of tizanidine is not fully understood <ref> Katzung, Bertram G. (30 November 2017). Basic & clinical pharmacology. Katzung, Bertram G. (Fourteenth ed.). New York. p. 487. ISBN 9781259641152. OCLC 1015240036 </ref> . | ||
Line 14: | Line 14: | ||
==Pharmacology== | ==Pharmacology== | ||
Tizanidine is an [[imidazoline]] derivative and centrally acting α<sub>2</sub> [[adrenergic]] [[agonist]] closely related to Clonidine. Tizanidine inhibits the release of excitatory amino acids from spinal interneurons. As a result, Tizanidine enhances the presynaptic inhibition of motor neurons. | Tizanidine is an [[imidazoline]] derivative and centrally acting α<sub>2</sub> [[adrenergic]] [[agonist]] closely related to Clonidine. Tizanidine inhibits the release of excitatory amino acids from spinal interneurons. As a result, Tizanidine enhances the presynaptic inhibition of motor neurons <ref> Ghanavatian S, Derian A. Tizanidine. [Updated 2021 Aug 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519505/ </ref>. | ||
Tizanidine also has some affinity for the α<sub>1</sub> receptors, but to a lesser than Clonidine, which may explain why its cardiovascular effects are so much milder than that of Clonidine<ref> Ghanavatian S, Derian A. Tizanidine. [Updated 2021 Aug 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519505/ </ref>. Tizanidine has approximately one tenth to one fifteenth of the blood pressure lowering effect of clonidine <ref> Katzung, Bertram G. (30 November 2017). Basic & clinical pharmacology. Katzung, Bertram G. (Fourteenth ed.). New York. p. 487. ISBN 9781259641152. OCLC 1015240036 </ref> . | Tizanidine also has some affinity for the α<sub>1</sub> receptors, but to a lesser than Clonidine, which may explain why its cardiovascular effects are so much milder than that of Clonidine<ref> Ghanavatian S, Derian A. Tizanidine. [Updated 2021 Aug 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519505/ </ref>. Tizanidine has approximately one tenth to one fifteenth of the blood pressure lowering effect of clonidine <ref> Katzung, Bertram G. (30 November 2017). Basic & clinical pharmacology. Katzung, Bertram G. (Fourteenth ed.). New York. p. 487. ISBN 9781259641152. OCLC 1015240036 </ref> . | ||
Line 64: | Line 64: | ||
*'''[[Effect::Muscle relaxation]]''' | *'''[[Effect::Muscle relaxation]]''' | ||
*'''[[Effect::Physical euphoria]]''' - This effect is very mild and may not be pronounced at all in some users. | *'''[[Effect::Physical euphoria]]''' - This effect is very mild and may not be pronounced at all in some users. | ||
*'''[[Effect:: | *'''[[Effect::Spontaneous bodily sensations]]''' - It only occurs at higher doses as a result of low blood pressure and mostly at lips. | ||
*'''[[Effect::Perception of bodily heaviness]]''' | *'''[[Effect::Perception of bodily heaviness]]''' | ||
*'''[[Effect::Decreased blood pressure]]''' | *'''[[Effect::Decreased blood pressure]]''' | ||
*'''[[Effect::Decreased heart rate]]''' | *'''[[Effect::Decreased heart rate]]''' | ||
*'''[[Effect::Abnormal heartbeat]]''' | *'''[[Effect::Abnormal heartbeat]]''' | ||
*'''[[Effect::Dizziness]]''' - Because of the cardiovascular effects of | *'''[[Effect::Dizziness]]''' - Because of the cardiovascular effects of Tizanidine, users can become dizzy or lightheaded. | ||
*'''[[Effect::Headache]]''' - When taking excessive doses, headaches are a common side effect. | *'''[[Effect::Headache]]''' - When taking excessive doses, headaches are a common side effect. | ||
*'''[[Effect::Watery eyes]]''' | *'''[[Effect::Watery eyes]]''' | ||
Line 75: | Line 75: | ||
*'''[[Effect::Pupil constriction]]''' | *'''[[Effect::Pupil constriction]]''' | ||
*'''[[Effect::Dry mouth]]''' | *'''[[Effect::Dry mouth]]''' | ||
}} | |||
{{effects/visual| | {{effects/visual| | ||
*'''[[Effect::Acuity suppression]]''' - This effect typically presents itself at higher doses. | |||
*'''[[Effect:: | |||
====Distortions==== | ====Distortions==== | ||
Line 98: | Line 94: | ||
*'''[[Effect::Scenarios and plots]]''' | *'''[[Effect::Scenarios and plots]]''' | ||
}} | }} | ||
|{{effects/cognitive| | |{{effects/cognitive| | ||
*'''[[Effect::Cognitive fatigue]]''' | *'''[[Effect::Cognitive fatigue]]''' | ||
*'''[[Effect::Dream potentiation]]''' - Some users of tizanidine notice strange or increasingly vivid dreams after continuous use of tizanidine. | *'''[[Effect::Dream potentiation]]''' - Some users of tizanidine notice strange or increasingly vivid dreams after continuous use of tizanidine. | ||
Line 111: | Line 105: | ||
*'''[[Effect::Delirium]]''' - At extremely high doses, delirium can be induced. | *'''[[Effect::Delirium]]''' - At extremely high doses, delirium can be induced. | ||
*'''[[Effect::Sleepiness]]''' - This is the most prevalent cognitive effect of Tizanidine | *'''[[Effect::Sleepiness]]''' - This is the most prevalent cognitive effect of Tizanidine | ||
}} | }} | ||
Line 137: | Line 130: | ||
===Lethal dosage=== | ===Lethal dosage=== | ||
The [[LD50]] of oral tizanidine in rats was found to be 414mg/kg in rats and 235 mg/kg in mice<ref> https://www.drugbank.ca/drugs/DB00697 </ref>. | The [[LD50]] of oral tizanidine in rats was found to be 414mg/kg in rats and 235 mg/kg in mice<ref> https://www.drugbank.ca/drugs/DB00697 </ref>. | ||
In some cases, Tizanidine overdose can be reversed with naloxone; however, this is not the case with everyone <ref> Bader D, Adam A, Shaban M, Alyahya B. Pediatric tizanidine toxicity reversed with naloxone: a case report. Int J Emerg Med. 2021 Dec 14;14(1):73. doi: 10.1186/s12245-021-00397-y. PMID: 34906071; PMCID: PMC8903539. </ref> <ref> Spiller HA, Bosse GM, Adamson LA. Retrospective review of Tizanidine (Zanaflex) overdose. J Toxicol Clin Toxicol. 2004;42(5):593-6. doi: 10.1081/clt-200026978. PMID: 15462150. </ref>. | |||
===Tolerance and addiction potential=== | ===Tolerance and addiction potential=== | ||
While dependence is rare, use of Tizanidine exceeding 36mg daily over an extended period of time can lead to hypertensive withdrawals. In cases where dependence has been built, a user should taper to avoid a hypertensive crisis<ref> "Tizanidine Hydrochloride Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 3 March 2019. </ref>. | While dependence is rare, use of Tizanidine exceeding 36mg daily over an extended period of time can lead to hypertensive withdrawals. In cases where dependence has been built, a user should taper to avoid a hypertensive crisis<ref> "Tizanidine Hydrochloride Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 3 March 2019. </ref>. | ||
Line 145: | Line 141: | ||
==Legal status== | ==Legal status== | ||
{{LegalStub}} | {{LegalStub}} | ||
* '''Austria:''' Tizanidine is available by prescription only. | |||
* '''Turkey:''' Tizanidine is available in pharmacies without prescription. | |||
* '''United States:''' Tizanidine is available by prescription only. | * '''United States:''' Tizanidine is available by prescription only. | ||
* '''United Kingdom:''' Tizanidine is available by prescription only. | * '''United Kingdom:''' Tizanidine is available by prescription only. | ||
Line 156: | Line 154: | ||
==External links== | ==External links== | ||
* [https://en.wikipedia.org/wiki/Tizanidine (Wikipedia)] | *[https://en.wikipedia.org/wiki/Tizanidine Tizanidine (Wikipedia)] | ||
* [https://erowid.org/experiences/subs/exp_Tizanidine.shtml Tizanidine (Erowid Vault)] | *[https://isomerdesign.com/pihkal/explore/15021 Tizanidine (IsomerDesign)] | ||
* [https:// | *[https://erowid.org/experiences/subs/exp_Tizanidine.shtml Tizanidine (Erowid Vault)] | ||
*[https://go.drugbank.com/drugs/DB00697 Tizanidine (DrugBank)] | |||
==References== | ==References== | ||
<references /> | <references /> | ||
[[Category:Psychoactive substance]][[Category: | [[Category:Psychoactive substance]] | ||
[[Category:Arylaminoimidazoline]] | |||
[[Category:Depressant]] |